Abstract
Recent advances in the preparation and characterization of metal core-based nanoparticles have opened the way to their exploration as carriers for carbohydrate-based vaccines. Here we describe the protocols for the preparation and characterization of water dispersible gold nanoparticles (1–3 nm gold diameter) as carriers for carbohydrate antigens. We mainly refer to the protocols we used for the preparation of gold glyconanoparticles as carrier for an S. pneumoniae carbohydrate-antigen. The high number of ligands at the gold nanoparticles surface and the easiness of their one-pot preparation make these biocompatible nanomaterials an attractive tool for glyco-scientists.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
You CC, Chompoosor A, Rotello VM (2007) The biomacromolecule-nanoparticle interface. Nano Today 2:34–43
Marradi M, Chiodo F, García I et al (2013) Glyconanoparticles as multifunctional and multimodal carbohydrate systems. Chem Soc Rev 42:4728–4745
Berti F, Adamo R (2013) Recent mechanistic insights on glycoconjugate vaccines and future perspectives. ACS Chem Biol 8:1653–1663
Astronomo RD, Burton DR (2010) Carbohydrate vaccines: developing sweet solutions to sticky situations? Nat Rev Drug Discov 9:308–324
Svarovskya SA, Szekely Z, Barchi JJ Jr (2005) Synthesis of gold nanoparticles bearing the Thomsen–Friedenreich disaccharide: a new multivalent presentation of an important tumor antigen. Tetrahedron Asymmetry 16:587–598
Ojeda R, de Paz JL, Barrientos AG et al (2007) Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines. Carbohydr Res 342:448–459
Safari D, Marradi M, Chiodo F et al (2012) Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine. Nanomedicine 7:651–662
Brinãs RP, Sundgren A, Sahoo P et al (2012) Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines. Bioconjug Chem 23:1513–1523
Manea F, Bindoli C, Fallarini S et al (2008) Multivalent, saccharide-functionalized gold nanoparticles as fully synthetic analogs of Type A Neisseria meningitidis antigens. Adv Mater 20:4348–4352
Parry AL, Clemson NA, Ellis J et al (2013) ‘Multicopy multivalent’ glycopolymer-stabilized gold nanoparticles as potential synthetic cancer vaccines. J Am Chem Soc 135:9362–9365
Di Gianvincenzo P, Marradi M, Martinez-Avila OM et al (2010) Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents. Bioorg Med Chem Lett 20:2718–2721
Chiodo F, Marradi M, Park J et al (2014) Galactofuranose-coated gold nanoparticles elicit a pro-inflammatory response in human monocyte-derived dendritic cells and are recognized by DC-SIGN. ACS Chem Biol 9:383–389
Irure A, Marradi M, Arnáiz B et al (2013) Sugar/gadolinium-loaded gold nanoparticles for labelling and imaging cells by magnetic resonance imaging. Biomater Sci 1:658–668
Frigell J, García I, Gómez-Vallejo V et al (2014) 68Ga-labeled gold glyconanoparticles for exploring blood-brain barrier permeability: preparation, biodistribution studies, and improved brain uptake via neuropeptide conjugation. J Am Chem Soc 136:449–457
Marradi M, Martín-Lomas M, Penadés S (2010) Glyconanoparticles polyvalent tools to study carbohydrate-based interactions. Adv Carbohydr Chem Biochem 64:211–290
Brust M, Walker M, Bethell D et al (1994) Synthesis of thiol derivatised gold nanoparticles in a two-phase liquid/liquid system. J Chem Soc Chem Commun 7:801–802
de la Fuente JM, Barrientos AG, Rojas TC et al (2001) Gold glyconanoparticles as water-soluble polyvalent models to study carbohydrate interactions. Angew Chem Int Ed 40:2257–2261
Chiodo F, Marradi M, Tefsen B et al (2013) High sensitive detection of carbohydrate binding proteins in an ELISA-solid phase assay based on multivalent glyconanoparticles. PLoS One 8:e73027
Avci FY, Li X, Tsuji M et al (2011) A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nat Med 17:1602–1609
Barrientos AG, de la Fuente JM, Rojas TC et al (2003) Gold glyconanoparticles: synthetic polyvalent ligands mimicking glycocalyx-like surfaces as tools for glycobiological studies. Chem Eur J 9:1909–1921
Hostetler MJ, Wingate JE, Zhong C-J et al (1998) Alkanethiolate gold cluster molecules with core diameters from 1.5 to 5.2 nm: core and monolayer properties as a function of core size. Langmuir 14:17–30
Martínez-Avila O, Hijazi K, Marradi M et al (2009) Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN. Chem Eur J 15:9874–9888
Acknowledgement
We thank Soledad Penadés for her scientific support throughout the last years. MM acknowledges COST Action CM1102 and the Department of Education, Universities and Research of the Basque Government (Project PI2012–46).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Chiodo, F., Marradi, M. (2015). Gold Nanoparticles as Carriers for Synthetic Glycoconjugate Vaccines. In: Lepenies, B. (eds) Carbohydrate-Based Vaccines. Methods in Molecular Biology, vol 1331. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2874-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2874-3_10
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2873-6
Online ISBN: 978-1-4939-2874-3
eBook Packages: Springer Protocols